Manufacturing Oligonucleotides from Bench to Bed

Marc M. LeMaitre, PhD, M_L Consult

Aptamers and SELEX: The Past, the Present and the Future

Paloma Giangrande, PhD, University of Iowa

Addressing Delivery Hurdles in the Translation of Oligonucleotide Therapeutics

Paul Burke, PhD, Burke Bioventures

Non Clinical Strategies for Oligonucleotide Development Programs

Jennifer Lockridge, PhD,  Dicerma Pharmaceuticals

Q&A

Jennifer Lockridge, PhD Paloma Giagrande, PhD Paul Burke, PhD Marc M. Lemaitre, PhD

Gerwirtz Memorial Scholarship Award

Inhibition of HIV-1 by Gymnotically Delivered 2′-Deoxy-2′-Fluoro-D-Arabinonucleic Acid Modified Antisense Oligonucleotides (2′-FANA ASOs)

Mayumi Takahashi, PhD, Beckman Research Institute, City of Hope 

Young Investigator Award

Preclinical Development of Tricyclo-DNA Antisense Oligonucleotides for the Treatment of Neuromuscular Diseases

Aurélie Goyenvalle, PhD, Université Saint Quentin en Yvelines

Paper of the Year

Single-Molecule Imaging Reveals that Argonaute Reshapes the Binding Properties of Its Nucleic Acid Guides

Victor Serebrov, PhD, RNA Therapeutics Institute, Mass Medical Center